Hurwitz AA - Search Results

1

Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.

Hurwitz AA, Foster BA, Kwon ED, Truong T, Choi EM, Greenberg NM, Burg MB, Allison JP. Hurwitz AA, et al. Cancer Res. 2000 May 1;60(9):2444-8. Cancer Res. 2000. PMID: 10811122

2

Prostate cancer: advances in immunotherapy.

Hurwitz AA, Yanover P, Markowitz M, Allison JP, Kwon ED. Hurwitz AA, et al. BioDrugs. 2003;17(2):131-8. doi: 10.2165/00063030-200317020-00005. BioDrugs. 2003. PMID: 12641491 Review.

3

Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.

Hurwitz AA, Sullivan TJ, Krummel MF, Sobel RA, Allison JP. Hurwitz AA, et al. J Neuroimmunol. 1997 Mar;73(1-2):57-62. doi: 10.1016/s0165-5728(96)00168-3. J Neuroimmunol. 1997. PMID: 9058759

4

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Hurwitz AA, Yu TF, Leach DR, Allison JP. Hurwitz AA, et al. Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10067-71. doi: 10.1073/pnas.95.17.10067. Proc Natl Acad Sci U S A. 1998. PMID: 9707601 Free PMC article.

5

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.

van Elsas A, Hurwitz AA, Allison JP. van Elsas A, et al. Among authors: hurwitz aa. J Exp Med. 1999 Aug 2;190(3):355-66. doi: 10.1084/jem.190.3.355. J Exp Med. 1999. PMID: 10430624 Free PMC article.

6

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

Kwon ED, Foster BA, Hurwitz AA, Madias C, Allison JP, Greenberg NM, Burg MB. Kwon ED, et al. Among authors: hurwitz aa. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15074-9. doi: 10.1073/pnas.96.26.15074. Proc Natl Acad Sci U S A. 1999. PMID: 10611340 Free PMC article.

7

The TRAMP mouse as a model for prostate cancer.

Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED. Hurwitz AA, et al. Curr Protoc Immunol. 2001 Nov;Chapter 20:20.5.1-20.5.23. doi: 10.1002/0471142735.im2005s45. Curr Protoc Immunol. 2001. PMID: 18432778

8

The role of CTLA-4 in the regulation and initiation of T-cell responses.

Chambers CA, Krummel MF, Boitel B, Hurwitz A, Sullivan TJ, Fournier S, Cassell D, Brunner M, Allison JP. Chambers CA, et al. Immunol Rev. 1996 Oct;153:27-46. doi: 10.1111/j.1600-065x.1996.tb00919.x. Immunol Rev. 1996. PMID: 9010718 Review. No abstract available.

9

A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?

Allison JP, Chambers C, Hurwitz A, Sullivan T, Boitel B, Fournier S, Brunner M, Krummel M. Allison JP, et al. Novartis Found Symp. 1998;215:92-8; discussion 98-102, 186-90. doi: 10.1002/9780470515525.ch7. Novartis Found Symp. 1998. PMID: 9760573 Review.

10

Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice.

Hurwitz AA, Sullivan TJ, Sobel RA, Allison JP. Hurwitz AA, et al. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3013-7. doi: 10.1073/pnas.042684699. Epub 2002 Feb 26. Proc Natl Acad Sci U S A. 2002. PMID: 11867713 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters